Catalog No.
YVV07901
Expression system
E. coli
Species
Nipah virus (NiV)
Protein length
Gln71-Thr602
Predicted molecular weight
61.59 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q9IH62
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Glycoprotein G, G
An Intein-Spliced Nipah G Protein Ferritin Nanoparticle Vaccine Provides Complete Protection against Lethal Nipah Virus Challenge., PMID:40455749
Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice., PMID:40333318
Investigating small molecules in propolis as Nipah virus glycoprotein (NiV-G) inhibitors through molecular interaction studies., PMID:40051842
An emerging zoonotic disease to be concerned about - a review of the nipah virus., PMID:39468679
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection., PMID:39217188
Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein., PMID:39134522
Recuperative potential of Indian medicinal plant compounds- a tool to encumber henipaviruses: an in -silico study., PMID:39099797
Structural insights into the Langya virus attachment glycoprotein., PMID:38815575
A Luciferase Immunosorbent Assay Based on Attachment Glycoprotein for the Rapid and Easy Detection of Nipah Virus IgG Antibodies., PMID:38792812
Pangenomic and immunoinformatics based analysis of Nipah virus revealed CD4+ and CD8+ T-Cell epitopes as potential vaccine candidates., PMID:38035008
Bioinformatic investigation of Nipah virus surface protein mutations: Molecular docking with Ephrin B2 receptor, molecular dynamics simulation, and structural impact analysis., PMID:37812043
Predicting the changes in neutralizing antibody interaction with G protein derived from Bangladesh isolates of Nipah virus: molecular dynamics based approach., PMID:37643003
A study on the design of an in silico self-amplifying mRNA vaccine against Nipah virus using immunoinformatics., PMID:36744525
Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system., PMID:36680637
IFITM3 promotes NiV envelope protein-mediated entry into MDCK cells and interacts with the fusion subunit of the F protein., PMID:36330888
Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates., PMID:34696372
Proteome Based Approach Defines Candidates for Designing a Multitope Vaccine against the Nipah Virus., PMID:34502239
EphrinB2 clustering by Nipah virus G is required to activate and trap F intermediates at supported lipid bilayer-cell interfaces., PMID:33571127
Multi-step molecular docking and dynamics simulation-based screening of large antiviral specific chemical libraries for identification of Nipah virus glycoprotein inhibitors., PMID:33450550
Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy., PMID:32933033
Phylogenetic and genetic analyses of the emerging Nipah virus from bats to humans., PMID:32622923
Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice., PMID:32340278
A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice., PMID:31878180
Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera., PMID:31513861
Emergence and adaptive evolution of Nipah virus., PMID:31408582
Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody., PMID:30995971
Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs., PMID:29708971
Formation of high-order oligomers is required for functional bioactivity of an African bat henipavirus surface glycoprotein., PMID:29685227
Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation., PMID:28974687
In silico identification and characterization of common epitope-based peptide vaccine for Nipah and Hendra viruses., PMID:28756915
Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response., PMID:27544586
Eukaryotic elongation factor 1-beta interacts with the 5' untranslated region of the M gene of Nipah virus to promote mRNA translation., PMID:27236461
Status of vaccine research and development of vaccines for Nipah virus., PMID:26973068
Water Dynamics at Protein-Protein Interfaces: Molecular Dynamics Study of Virus-Host Receptor Complexes., PMID:25420132
Attachment protein G of an African bat henipavirus is differentially restricted in chiropteran and nonchiropteran cells., PMID:25100832
Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus., PMID:24508193
[Study of pathogenicity of Nipah virus and its vaccine development]., PMID:25765986
Characterization of African bat henipavirus GH-M74a glycoproteins., PMID:24296468
Individual N-glycans added at intervals along the stalk of the Nipah virus G protein prevent fusion but do not block the interaction with the homologous F protein., PMID:23283956
Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines., PMID:23175762
Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens., PMID:22226962
Triggering of the newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptors., PMID:21460213
Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach., PMID:21177820
Nipah virus infection and glycoprotein targeting in endothelial cells., PMID:21054904
Tyrosine residues in the cytoplasmic domains affect sorting and fusion activity of the Nipah virus glycoproteins in polarized epithelial cells., PMID:20484517
Assembly and biological and immunological properties of Newcastle disease virus-like particles., PMID:20181713
Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail., PMID:19108727
Human neuronal cell protein responses to Nipah virus infection., PMID:17553172
Molecular characteristics of the Nipah virus glycoproteins., PMID:17470910
Efficacy of DNA immunization with F and G protein genes of Nipah virus., PMID:17135518
For research use only. Not for human or drug use.
